The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders

Neuroscience Letters

Volumn 426, Issue 1, 2007, Pages 49-53

  Kurt, Erhan ^a   Guler, Ozkan ^b   Serteser, Mustafa ^b   Cansel, Neslihan ^c   Ozbulut, Omer ^b   Altinbaş, Kurşat ^a   Alataş, Gazi ^a   Savaş, Haluk ^c   Gecici, Omer ^b  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

BMI; Depression; Electroconvulsive therapy; Ghrelin; Leptin; Mania

Indexed keywords

CHOLESTEROL; GHRELIN; LEPTIN;

ADULT; ARTICLE; BIPOLAR DISORDER; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; MALE; MANIA; MOOD DISORDER; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN; BRAIN CHEMISTRY; CHOLESTEROL; DEPRESSIVE DISORDER; DOWN-REGULATION; ELECTROCONVULSIVE THERAPY; FEMALE; GHRELIN; HUMANS; LEPTIN; MALE; MIDDLE AGED; MOOD DISORDERS; TREATMENT OUTCOME; UP-REGULATION;

EID: 34548842474     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.08.018     Document Type: Article

References (27)

1. Ackenhcil M. Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis. J. Affect. Disord. 62 1-2 (2001) 101-111
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Washington, DC, APA, 1994.
3. Angelucci F., Aloe L., Jimenez-Vasquez P., and Mathe A.A. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J. ECT 18 (2002) 138-143
4. Atmaca M., Kuloglu M., Tezcan E., and Ustundag B. Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology 46 2 (2002) 67-69
5. Atmaca M., Kuloglu M., Tezcan E., Ustundag B., and Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 46 4 (2002) 176-179
6. Bates S.H., and Myers M.G. The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol. Metab. 14 (2003) 447-452
7. Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., and Vacca M. Effects of ghrelin and amylin on dopamine, noepinephrine and serotonin release in the hypothalamus. Eur. J. Pharmacol. 454 (2002) 189-192
8. Carlini V.P., Varas M.M., Cragnolini A.B., Schiöth H.B., Scimonelli T.N., and de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem. Biophys. Res. Commun. 313 (2004) 635-641
9. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
10. Eşel E., Bastürk M., Kula M., Reyhancan M., Turan M.T., and Sofuoglu S. Effects of electroconvulsive therapy on pituitary hormones in depressed patients. Bull. Clin. Psychopharmacol. 13 (2003) 109-117
11. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (1997), American Psychiatric Press, Inc., Washington, USA
12. Gecici O., Serteser M., Emül M., and Demirel R. Serum ghrelin and leptin levels in major depressive disorders. Neurol. Psychiatry Brain Res. 12 (2005) 47-52
13. Green A.R., Heal D.J., Johnson P., Laurence B.E., and Nimgaonkar V.L. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamineand dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br. J. Pharmacol. 80 (1983) 377-385
14. Hinze-Selch D., Schuld A., Kraus T., Kuhn M., Uhr M., and Pollmächer T. Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23 (2000) 13-19
15. Horvath T.L., Diano S., Sotonyi P., Heiman M., and Tschoöp M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 142 (2001) 4163-4169
16. Kraus T., Haack M., Schuld A., Hinze-Selch D., Koethe D., and Pollmacher T. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 35 (2002) 220-225
17. Leibowitz S.F., and Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 44 (1998) 851-864
18. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
19. Mann J.J. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J. ECT 14 (1998) 172-180
20. Murashita M., Kusumi I., Inoue T., Takahashi Y., Hosoda H., Kangawa K., and Koyama T. Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30 (2005) 106-110
21. Pagnin D., de Quriroz V., Pini S., and Cassano G.B. Efficacy of ECT in depression: a meta-analytic review. J. ECT 20 (2004) 13-20
22. Schmid D.A., Held K., Ising M., Uhr M., Weikel J.C., and Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 30 (2005) 1187-1192
23. Suzuki K., Awata S., Takano T., Ebina Y., Takamatsu K., Kajiwara T., Ito K., Shindo T., Funakoshi S., and Matsuoka H. Improvement of psychiatric symptoms after electroconvulsive therapy in young adults with intractable first-episode schizophrenia and schizophreniform disorder. Tohoku J. Exp. Med. 210 3 (2006) 213-220
24. Togo T., Hasegawa K., Miura S., Hosojima H., Kojima K., Shoji M., Kase A., Uchikado H., Iseki E., and Kosaka K. Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology 172 (2004) 230-232
25. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., Ghatei M.A., and Bloom S.R. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76 5 (2002) 316-324
26. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., and Hishikawa Y. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 22 (1998) 435-444
27. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 6505 (1994) 425-432